[
    [
        {
            "time": "",
            "original_text": "凯莱英：公司股东、副总经理黄小莲减持8400股 减持股份",
            "features": {
                "keywords": [
                    "凯莱英",
                    "黄小莲",
                    "减持",
                    "8400股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英：公司股东、副总经理黄小莲减持8400股 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "凯莱英(002821.SZ)：副总经理黄小莲减持量过半累计减持8400股 减持股份",
            "features": {
                "keywords": [
                    "凯莱英",
                    "黄小莲",
                    "减持量过半",
                    "8400股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英(002821.SZ)：副总经理黄小莲减持量过半累计减持8400股 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "一季度融资交易完成数量TOP10，医药相关行业占了3个",
            "features": {
                "keywords": [
                    "一季度",
                    "融资交易",
                    "TOP10",
                    "医药相关行业",
                    "3个"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一季度融资交易完成数量TOP10，医药相关行业占了3个",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]